LUMICKS Technologies

BiotechnologySeries DAmsterdam, Netherlandslumicks.com

Latest round

Series D

Last raised

Apr 2021

Total raised

$93M

Investors

8

About LUMICKS Technologies

V. is focused on providing scientific instruments for academic and pharmaceutical research. Rowe Price.LUMICKS offers advanced technologies primarily designed for academic and pharmaceutical research, focusing on biomolecular mechanisms and cellular interactions. Their core products include Cell Avidity, which quantifies binding strength between cells and proteins, and Dynamic Single-Molecule solutions for real-time observation of molecular interactions.60.V. secured EUR 20 million in venture debt from the European Investment Bank. The company plans to expand its offerings and may target new markets in North America and Asia by 2025, enhancing their product portfolio to better serve the growing needs in these regions.

Who invested in LUMICKS Technologies

8 investors across 2 rounds

See all investors in LUMICKS Technologies

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series D

    Apr 16, 2021

    Amount

    $93M

    Investors

    Locked

  2. Series A

    Jan 1, 2017

    Amount

    Undisclosed

    Investors

    Locked

Questions about LUMICKS Technologies

Who invested in LUMICKS Technologies?

LUMICKS Technologies has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has LUMICKS Technologies raised?

LUMICKS Technologies has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did LUMICKS Technologies last raise money?

LUMICKS Technologies's most recent round on record is a Series D, in Apr 2021.

What does LUMICKS Technologies do?

LUMICKS Technologies is a biotechnology company.

Where is LUMICKS Technologies headquartered?

LUMICKS Technologies is headquartered in Amsterdam, Netherlands.

Which VCs invest in companies like LUMICKS Technologies?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at LUMICKS Technologies's stage. Their profiles are linked below.

Raising like LUMICKS Technologies? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.